Source: Annual Congress 2011 - Airways disease comorbidities and general aspects
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Brusse-Keizer, P. van der Valk, J. van der Palen (Enschede, Netherlands). Differences in adherence to inhaled steroid medication in COPD. Eur Respir J 2011; 38: Suppl. 55, 3999

Member's Comments

No comment yet.

Related content which might interest you: Patterns of adherence to inhaled corticosteroids Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Determinants of adherence to inhaled corticosteroids in children with asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Patients‘ beliefs about inhaled corticosteroids (ICS): relationship with adherence Source: Annual Congress 2008 - Social determinants and psychological issues in primary care respiratory diseases Year: 2008 Measures to assess adherence to inhaled corticosteroids for asthma Source: Eur Respir J 2003; 22: Suppl. 45, 294s Year: 2003 Low adherence to inhaled corticosteroids/long-acting ß2-agonists and biologic treatment in severe asthmatics Source: ERJ Open Res, 6 (2) 00017-2020; 10.1183/23120541.00017-2020 Year: 2020 ERS guideline on withdrawal of inhaled corticosteroids in COPD Source: ERS webinar 2021: ERS guideline on withdrawal of inhaled corticosteroids in COPD Year: 2021 Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence Year: 2021 Adherence of stable COPD patients to inhaled pharmacotherapy Source: Annual Congress 2011 - COPD management Year: 2011 Patients with underuse and overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhalation medication Source: International Congress 2017 – Inhalers and their use Year: 2017 Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Inhaled steroids prescribing in patients with COPD in the community Source: Eur Respir J 2001; 18: Suppl. 33, 59s Year: 2001 The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004 High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs Source: Eur Respir J 2012; 40: 1072-1074 Year: 2012 Bronchodilator reversibility and short-term inhaled corticosteroid response in Japanese patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 341s Year: 2004 Differences in adherence to common inhaled medications in COPD Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002 Estimate of asthma control and adherence to inhaled corticosteroids in children with asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Efficacy of indacaterol in COPD is maintained irrespective of inhaled corticosteroid (ICS) use Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011